COURT-RULING ·Filed Sep 14, 2026

ABBV

AbbVie Inc.
NEUTRAL
Impact 5/10
Horizondays Processed16d 12h ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

New Mexico federal court denied AbbVie's motion for a preliminary injunction against H.B. 78, a state law restricting manufacturer data demands in the 340B program. The ruling rejects AbbVie's federal preemption arguments, allowing the state law to proceed. Financial impact is limited near-term: the law is narrow (New Mexico only), the federal Rebate Program is not yet operative, and the ruling is a preliminary denial, not a final merits decision. The stock has historically absorbed similar neutral rulings without sustained downside.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+5d
ABBV ▲ +1.04% at T+5d
NEUTRAL call ✓ call won +1.04% · α vs SPY -0.62% · entry $261.77 → $264.48
Next anchor: T+20d in 7d
Latest observation: T+11 +3.05% FF3 residual α
Entry anchored
Sep 11, 05:10 PM ET
via 1-min bar
T+1d
+0.49%
call +0.49% · α +0.94%
$263.04
settled 18d ago
T+5d
+1.04%
call +1.04% · α -0.62%
$264.48
settled 14d ago
T+20d
—
call — · α —
—
in 7d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

New Mexico federal court denied AbbVie's motion for a preliminary injunction against H.B. 78, a state law restricting manufacturer data demands in the 340B program. The ruling rejects AbbVie's federal preemption arguments, allowing the state law to proceed. Financial impact is limited near-term: the law is narrow (New Mexico only), the federal Rebate Program is not yet operative, and the ruling is a preliminary denial, not a final merits decision. The stock has historically absorbed similar neutral rulings without sustained downside.

Financial Impact

Not specified

Market Snapshot

Price
$263.00
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (39 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-266eea10b1-ABBV
14 reports for ABBV
Performance horizon
100% Hit rate 6 of 6 directional calls best @ T+60▲ +27.21%Apr 29, 2026
Filters
Rows
Reports for ABBV — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
Court Ruling
NEUTRAL ★ 5/10
$261.77 $264.48▲ +1.04%▼ −0.62%$259.93 (−0.70%)
Sep 3, 2026
29d ago
8-K
NEUTRAL ★ 4/10
$260.21 $257.12▼ −1.19%▼ −0.04%$259.93 (−0.11%)
Aug 5, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$243.87 $250.82▲ +2.85%▲ +1.64%$259.93 (+6.59%)
Aug 3, 2026
8w ago
Institutional Cluster
MIXED ★ 5/10
$245.10 $247.97▲ +1.17%▼ −0.86%$259.93 (+6.05%)
Aug 3, 2026
8w ago
Court Ruling
NEUTRAL ★ 1/10
$245.10 $247.97▲ +1.17%▼ −0.86%$259.93 (+6.05%)
Jul 31, 2026
9w ago
8-K
BULLISH ★ 7/10
$250.94 $246.04▼ −1.95%▼ −5.46%$259.93 (+3.58%)
Jul 27, 2026
9w ago
Court Ruling
BULLISH ★ 6/10
$256.91 $250.94▼ −2.32%▼ −3.40%$259.93 (+1.18%)
Jun 22, 2026
14w ago
8-K
BULLISH ★ 7/10
$230.01 $254.31▲ +10.56%▲ +11.02%$259.93 (+13.01%)
May 18, 2026
19w ago
Court Ruling
NEUTRAL ★ 3/10
$209.41 $213.12▲ +1.77%▲ +0.15%$259.93 (+24.12%)
Apr 29, 2026
22w ago
8-K
BULLISH ★ 7/10
$203.89 $206.11▲ +1.09%▼ −2.02%$259.93 (+27.49%)
Showing 10 of 14

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access